Methylation-mediated silencing of Dlg5 facilitates bladder cancer metastasis

Zhihua Zhou1, Yifeng Guo1, Yong Liu1

  • 1Department of Urology, Shanghai First People׳s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200008, China.

Abstract

Insights

Discs large homolog 5 (Dlg5) downregulation, driven by DNA hypermethylation, promotes bladder cancer metastasis and predicts poor survival. Loss of Dlg5 function enhances tumor invasiveness.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Discs large homolog 5 (Dlg5) is a scaffolding protein implicated in cancer progression.
  • The specific role of Dlg5 in bladder cancer metastasis remains largely unexplored.

Purpose of the Study:

  • To investigate the expression patterns of Dlg5 in human bladder cancer.
  • To elucidate the functional significance of Dlg5 in bladder cancer metastasis and its association with patient survival.

Main Methods:

  • Analysis of Dlg5 expression in bladder cancer tissues and adjacent normal tissues.
  • DNA methylation analysis of the Dlg5 gene in bladder cancer cell lines and tumors.
  • Functional studies involving Dlg5 knockdown to assess effects on cell invasion and metastasis.
  • Kaplan-Meier survival analysis to correlate Dlg5 expression with patient outcomes.

Main Results:

  • Dlg5 expression is significantly decreased in bladder cancer tissues, particularly in muscle-invasive tumors.
  • DNA hypermethylation of the Dlg5 gene correlates with its reduced expression in bladder tumors.
  • Knockdown of Dlg5 enhances bladder cancer cell invasion in vitro and promotes metastasis in vivo.
  • Downregulation of Dlg5 is significantly associated with reduced overall survival in bladder cancer patients.

Conclusions:

  • DNA hypermethylation-induced inhibition of Dlg5 contributes to the invasive phenotype of bladder tumors.
  • Dlg5 acts as a tumor suppressor in bladder cancer, and its downregulation is a marker for poor prognosis.